论文部分内容阅读
丙氟哌酸(Ciprofloxacin)是一个新的口服广谱喹诺酮羧酸衍生物,它对革蓝氏阳性和阴性细菌的抗菌作用比第三代喹诺酮羧酸类(如氟嗪酸、氟哌酸、甲氟哌酸、氟啶酸和氨氟哌酸)强,其抗绿脓杆菌的强度可以与第三代头孢菌素比美。本文用丙氟哌酸治疗皮肤软组织感染26例、泌尿系感染12例、骨髓炎和腹部感染各4例、呼吸系感染2例,共48例。其中26例有基础病如糖尿病、肝硬变和癌症。48例中,24例为绿脓杆菌感染,13
Ciprofloxacin is a new orally administered broad spectrum of quinolonecarboxylic acid derivatives that is more potent against Gram-positive and -negative bacteria than the third-generation quinolonecarboxylic acids (such as trifloxacin, norfloxacin, Methicillin, nifedipine, and nifedipine) are strong, and their strength against Pseudomonas aeruginosa can be comparable to that of the third generation cephalosporins. In this paper, propofol treatment of skin and soft tissue infections in 26 cases, 12 cases of urinary tract infection, osteomyelitis and abdominal infections in 4 cases, respiratory infection in 2 cases, a total of 48 cases. 26 cases of basic diseases such as diabetes, cirrhosis and cancer. In 48 cases, 24 cases were Pseudomonas aeruginosa infection, 13